Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been used to successfully treat primary liver cancer (PLC); however, identifying modifiable patient factors associated with therapeutic benefits is challenging. Obesity is known to be associated with increased survival after ICI treatment; however...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Lu-shan, Li, Rui-ning, Cui, Hao, Hong, Chang, Huang, Chao-yi, Li, Qi-mei, Hu, Cheng-yi, Dong, Zhong-yi, Zhu, Hong-bo, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258103/
https://www.ncbi.nlm.nih.gov/pubmed/35794525
http://dx.doi.org/10.1186/s12885-022-09823-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258103/
https://www.ncbi.nlm.nih.gov/pubmed/35794525
http://dx.doi.org/10.1186/s12885-022-09823-7

Ejemplares similares